thalidomide has been researched along with curcumin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Feierl, G; Höllwarth, M; Kobayashi, H; Kotanko, P; Petnehazy, T; Schimpl, G; Weber-Mzell, D; Zaupa, P | 1 |
Muriel, P; Rivera-Espinoza, Y | 1 |
Aggarwal, BB; Anand, P; Guha, S; Kunnumakkara, AB; Sethi, G; Sung, B | 1 |
Kay, NE; O'Brien, S | 1 |
Chojnacki, J; Du, Y; Fu, H; Grant, S; Liu, K; Zhang, D; Zhang, S | 1 |
Babakhani, D; Bahadoran, M; Chahardouli, B; Dashti, N; Haghi, A; Mohammadi Kian, M; Mohammadi, S; Nikbakht, M; Rostami, S; Salemi, M | 1 |
2 review(s) available for thalidomide and curcumin
Article | Year |
---|---|
Beneficial drugs for liver diseases.
Topics: Adrenal Cortex Hormones; Animals; Colchicine; Curcumin; Disease Models, Animal; Drug Combinations; Glycyrrhizic Acid; Humans; Interferons; Liver Diseases; Nitric Oxide; Plant Extracts; Resveratrol; S-Adenosylmethionine; Silymarin; Stilbenes; Thalidomide | 2008 |
Maintenance therapy for B-chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal, Murine-Derived; Catechin; Curcumin; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Rituximab; Thalidomide | 2011 |
5 other study(ies) available for thalidomide and curcumin
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
The role of nuclear factor-kappa B in bacterial translocation in cholestatic rats.
Topics: Analysis of Variance; Animals; Bacterial Translocation; Cholestasis; Curcumin; Drugs, Chinese Herbal; Glutathione; Ileum; Lipid Peroxidation; Male; Malondialdehyde; Neutrophil Activation; NF-kappa B; Peroxidase; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Thalidomide; Xanthine Oxidase | 2006 |
Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Curcumin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Multiple Myeloma; NF-kappa B; Proto-Oncogene Proteins c-akt; Pyrazines; Signal Transduction; Thalidomide; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |
Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Multiple Myeloma; Reactive Oxygen Species; Structure-Activity Relationship; Thalidomide | 2013 |
Curcumin Combined with Thalidomide Reduces Expression of
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; STAT3 Transcription Factor; Structure-Activity Relationship; Thalidomide; Tumor Cells, Cultured | 2020 |